ARWR+432.86%14.3%
DYN+125.80%14.3%
FDMT+79.41%14.3%
IONS+33.18%14.3%
LRMR+8.75%14.3%
SLN+111.28%14.3%
TWST+344.05%14.3%
As of Aug 6, 2026, 4:25 AM ET
Biotech '25: RNA-Based/Genetic Medicine Constituents
4D Molecular Therapeutics, Inc.FDMT | 14.3% | 0.19% | 2.09% | -19.18% | 0.98% | 37.07% | 6.42% | 213.41% | 79.41% | $537.4M |
Arrowhead Pharmaceuticals, Inc.ARWR | 14.3% | -2.99% | 1.53% | 0.42% | 2.67% | 30.91% | 37.36% | 584.87% | 432.86% | $12.24B |
Dyne Therapeutics, Inc.DYN | 14.3% | 0.77% | 7.08% | 14.58% | 3.93% | 33.79% | 67.54% | 164.08% | 125.80% | $4.89B |
Ionis Pharmaceuticals, Inc.IONS | 14.3% | -1.60% | -4.17% | -34.85% | 4.67% | -31.50% | -33.22% | 88.75% | 33.18% | $8.96B |
Larimar Therapeutics, Inc.LRMR | 14.3% | -0.24% | 2.50% | 24.62% | 7.33% | 7.61% | -22.79% | 86.36% | 8.75% | $425.9M |
Silence Therapeutics plcSLN | 14.3% | 0.63% | 2.00% | 6.24% | 7.15% | 84.87% | 106.62% | 288.93% | 111.28% | $530.9M |
Twist Bioscience CorporationTWST | 14.3% | 15.65% | 27.41% | 15.09% | 25.63% | 262.58% | 145.12% | 200.99% | 344.05% | $7.16B |
| Theme return | — | 1.77% | 5.49% | 2.49% | 8.35% | 57.70% | 40.85% | 294.53% | 167.91% | — |
| Average | 14.3% | 1.77% | 5.49% | 0.99% | 7.48% | 60.76% | 43.86% | 232.48% | 162.19% | $4.96B |
| Median | 14.3% | 0.19% | 2.09% | 6.24% | 4.67% | 33.79% | 37.36% | 200.99% | 111.28% | $4.89B |
| Std Dev | 0.0% | 5.80% | 9.45% | 19.50% | 7.70% | 88.50% | 61.62% | 158.30% | 149.90% | $4.37B |
| Min | 14.3% | -2.99% | -4.17% | -34.85% | 0.98% | -31.50% | -33.22% | 86.36% | 8.75% | $425.9M |
| Max | 14.3% | 15.65% | 27.41% | 24.62% | 25.63% | 262.58% | 145.12% | 584.87% | 432.86% | $12.24B |
| % Positive Tickers | 57.14% | 85.71% | 71.43% | 100.00% | 85.71% | 71.43% | 100.00% | 100.00% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondary
About this theme
Biotech '25: RNA-Based/Genetic Medicine tracks 7 publicly listed stocks in this theme: ARWR, DYN, FDMT, IONS, LRMR, SLN, TWST. See the constituent table for details.